Atlas Trials

Ferric Carboxymaltose in Type 2 Diabetes Mellitus (T2DM) Patients With Iron Deficiency

Clinical trial NCT01513369 · COMPLETED

Trial details

NCT number
NCT01513369
Sponsor
GWT-TUD GmbH
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Type 2 Diabetes MellitusIron Deficiency
Start date
2012-08-01
Primary completion
2018-10-01
Enrollment
152

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.